Skip to main content
. 2015 Jul 1;23(1):99–126. doi: 10.1089/ars.2013.5776

Table 3.

Clinical Trials with Panobinostat (LBH-589) As Single Drug

NCT number Recruitment Study results Conditions Phases Funded by Primary completion date
NCT01802879 Not yet recruiting No results available Hematologic neoplasms 2 Industry July 2018
NCT01451268 Recruiting No results available MDS|AML 1/2 Other January 2016
NCT00663832 Completed No results available Prostate cancer 1 Industry December 2011
NCT01242774 Recruiting No results available AML 1 Industry November 2013
NCT01245179 Recruiting No results available Sickle cell disease 1 Other|Industry December 2013
NCT01034163 Completed No results available Hodgkin's lymphoma 3 Industry May 2012
NCT01065467 Active, not recruiting No results available Melanoma|Malignant melanoma 1 Other|Industry December 2012
NCT00840346 Recruiting No results available AML 1/2 Other September 2011
NCT00878436 Recruiting No results available Prostate cancer|Prostatic neoplasms 1/2 Other|Industry December 2013
NCT00985946 Completed No results available Neuroendocrine tumors 2 Other|Industry October 2012
NCT01613976 Recruiting No results available MDS|CMML|AML 1 Industry September 2013
NCT01136499 Completed No results available Soft tissue sarcoma 2 Other January 2012
NCT00742027 Active, not recruiting No results available Classical Hodgkin's lymphoma 2 Industry July 2013
NCT01680094 Active, not recruiting No results available HIV infection 1/2 Other|Industry March 2013
NCT01007968 Completed No results available Advanced solid tumors 1 Industry November 2012
NCT00670553 Completed No results available Prostate cancer|Head and neck cancer|Esophageal cancer 1 Industry January 2010
NCT00532389 Active, not recruiting No results available Multiple myeloma 1 Industry December 2012
NCT00739414 Completed No results available Cancer|Advanced solid tumor 1 Industry November 2009
NCT00570284 Completed No results available Cancer 1 Industry February 2011
NCT00550277 Completed Has results Renal cell carcinoma 2 Other|Industry March 2010
NCT01055483 Completed No results available Acute myeloid leukemia 1 Industry February 2012
NCT00412997 Completed No results available Tumors|Cutaneous T-cell lymphoma 1 Industry May 2008
NCT00936611 Active, not recruiting No results available Waldenstrom's macroglobulinemia 2 Other|Industry December 2012
NCT00667862 Completed No results available Prostate cancer 2 Industry November 2010
NCT01032148 Recruiting No results available Hodgkin's lymphoma|Non-Hodgkin's lymphoma 1 Other|Industry July 2013
NCT00490776 Completed No results available Cutaneous T-cell lymphoma 2/3 Industry September 2009
NCT00594230 Completed Has results MDS 2 Other|Industry March 2011
NCT00880269 Completed No results available Refractory leukemia|AML 2 Industry February 2012
NCT01523834 Recruiting No results available Diffuse large B-cell lymphoma 2 Other January 2014
NCT00535951 Completed No results available Carcinoma, non-small-cell lung|Mesothelioma 1 Industry January 2009
NCT00690677 Completed No results available Colorectal cancer 2 Other|Industry December 2011
NCT00449761 Completed No results available Leukemia, myeloid, chronic 2/3 Industry August 2008
NCT00532675 Active, not recruiting No results available Multiple myeloma 1 Industry October 2013
NCT00621244 Completed No results available Lymphoma|Leukemia|Multiple myeloma 1/2 Industry August 2009
NCT01222936 Completed No results available Small cell lung carcinoma 2 Other|Industry June 2009
NCT00451035 Completed No results available Chronic myeloid leukemia in chronic phase 2/3 Industry September 2008
NCT00777049 Active, not recruiting No results available Breast cancer 2 Other November 2012
NCT00939159 Active, not recruiting No results available Myelodysplastic syndrome 2 Other|Industry December 2014
NCT00425555 Active, not recruiting No results available Cutaneous T-cell lymphoma 2/3 Industry June 2013

CMML, chronic myelomonocytic leukemia.